Skip to main content

Featured Content

The stress of the COVID-19 pandemic and other intense current events of the past year has led an increased number of individuals to seek medical cannabis for mental health reasons, displacing chronic pain as the main reason for medical cannabis use, according to a study published this week.
A model of care that is grounded in evidence-based modalities of treatment, which integrates the science of medicine, the art of therapy and the compassion of spirituality into an experience that forges connection to self, others and a sense of meaning and purpose is highly effective in treating persons suffering from substance use disorder.
Preliminary data from researchers at the University of Pittsburgh Medical Center showed that naltrexone reduced both pain and disability in chronic pain patients when administered in low doses, according to a media report.
A study by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy found that 1 in 5 pharmacies refuse to dispense Suboxone, the medication that combines buprenorphine and naloxone.
With funding from a State Opioid Response 2.0 grant, the Ohio Department of Mental Health and Addiction Services will provide access to Pear Therapeutics' reSET and reSET-O digital therapeutics for the treatment of SUD and OUD.

Meetings & Publications

Back to Top